142 related articles for article (PubMed ID: 18375524)
1. MR imaging features of invasive breast cancer correlated with hormonal receptors: does progesterone receptor matter?
Chen JH; Nalcioglu O; Su MY
Ann Oncol; 2008 May; 19(5):1024-6. PubMed ID: 18375524
[No Abstract] [Full Text] [Related]
2. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
[No Abstract] [Full Text] [Related]
3. [Clinical-biological characteristics of infiltrating ductal carcinomas of the breast with estrogen receptor concentrations >300 fmol/mg protein].
Resino C; Arias JI; Del Río MC; Sánchez Hermosa C; Ruibal A
Rev Esp Med Nucl; 2001 Oct; 20(6):503-5. PubMed ID: 11578586
[No Abstract] [Full Text] [Related]
4. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.
Arpino G; Bardou VJ; Clark GM; Elledge RM
Breast Cancer Res; 2004; 6(3):R149-56. PubMed ID: 15084238
[TBL] [Abstract][Full Text] [Related]
5. [Hormone-dependent, diploid, infiltrating ductal breast carcinomas less than 2 cm in size: influence of an exclusive and moderate cellular proliferation on the clinicobiological features and recurrences of these malignant tumors].
Ruibal A; Arias JI
Rev Esp Med Nucl; 2002; 21(6):437-8. PubMed ID: 12425893
[No Abstract] [Full Text] [Related]
6. Correlations of survivin expression with clinicomorphological parameters and hormonal receptor status in breast ductal carcinoma.
Adamkov M; Kajo K; Vybohova D; Krajcovic J; Stuller F; Rajcani J
Neoplasma; 2012; 59(1):30-7. PubMed ID: 22103896
[TBL] [Abstract][Full Text] [Related]
7. Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence.
Coradini D; Pellizzaro C; Veneroni S; Ventura L; Daidone MG
Br J Cancer; 2002 Nov; 87(10):1105-11. PubMed ID: 12402149
[TBL] [Abstract][Full Text] [Related]
8. Pigmented Cutaneous Metastasis of Breast Carcinoma Mimicking a Melanoma.
Ubillos N; Vola M; Mazzei ME; Magliano J
Actas Dermosifiliogr; 2016 Oct; 107(8):699-701. PubMed ID: 27206606
[No Abstract] [Full Text] [Related]
9. A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas.
Soslow RA; Carlson DL; Horenstein MG; Osborne MP
Breast Cancer Res Treat; 2000 May; 61(2):161-70. PubMed ID: 10942102
[TBL] [Abstract][Full Text] [Related]
10. Estrogen and progesterone receptors in breast cancer.
Couch P
Am J Dermatopathol; 1997 Oct; 19(5):553-5. PubMed ID: 9335253
[No Abstract] [Full Text] [Related]
11. Differential sensitivity of estrogen/progesterone receptors and BRST-2 markers in metastatic ductal and lobular breast carcinoma to the skin.
Wallace ML; Smoller BR
Am J Dermatopathol; 1996 Jun; 18(3):241-7. PubMed ID: 8806958
[TBL] [Abstract][Full Text] [Related]
12. [Cytosolic pS2 levels and cellular proliferation in ER-positive and PgR-positive infiltrating ductal carcinomas of the breast].
Sánchez Salmón A; Argibay S; Arias JI; Ruibal A
Rev Esp Med Nucl; 2005; 24(3):185-90. PubMed ID: 15847785
[TBL] [Abstract][Full Text] [Related]
13. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
Yie SM; Luo B; Ye NY; Xie K; Ye SR
Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
[TBL] [Abstract][Full Text] [Related]
14. [Zosteriform eruption resistant to acyclovir].
Orgaz-Molina J; Cotugno M; Aneiros-Fernández J; Arias-Santiago S
Med Clin (Barc); 2013 Aug; 141(4):188. PubMed ID: 23597955
[No Abstract] [Full Text] [Related]
15. [Valoration of the epidermal growth factor receptor (EGFR) in benign breast disease and its relation with expression in malignant tumors classified by hormonal dependence].
Allende MT; Raigoso PF; Alvarez A; Llana B; Sánchez A; Martínez MI; Miralles MT; Roiz C
Rev Esp Med Nucl; 1999; 18(1):32-6. PubMed ID: 10074215
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of steroid hormone receptors with respect to tumor cellularity.
Geppert M; Smyczek-Gargya B; Dietl J; Schneider H
Zentralbl Pathol; 1993 Aug; 139(3):217-9. PubMed ID: 8218122
[TBL] [Abstract][Full Text] [Related]
17. [Study of the cytosolic concentrations of the tissue poly-peptide specific (TPS) antigen in infiltrating ductal carcinomas of the breast. Positive relationship with hormone dependency and negative with cellular proliferation].
Ruibal A; Arias JI; Resino C; Lapeña G; Schneider J; Tejerina A
Rev Esp Med Nucl; 2001 Aug; 20(5):365-8. PubMed ID: 11470070
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer.
García Vicente AM; Soriano Castrejón A; Relea Calatayud F; Muñoz Madero V; Molina Garrido MJ; León Martín AA; Cordero García JM; Pilkington Woll JP; Chacón López-Muñiz I; Palomar Muñoz A
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):308-14. PubMed ID: 23084013
[TBL] [Abstract][Full Text] [Related]
19. Progesterone receptor status and tumor size as possible indicators of axillary lymph node involvement in T1 carcinoma of the breast.
Ron IG; Kovner F; Lifschitz-Mercer B; Inbar MJ
Acta Oncol; 2001; 40(5):629-32. PubMed ID: 11669336
[TBL] [Abstract][Full Text] [Related]
20. DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-alpha, ER-beta and androgen receptor status.
Conde I; Alfaro JM; Fraile B; Ruíz A; Paniagua R; Arenas MI
Breast Cancer Res; 2004; 6(3):R140-8. PubMed ID: 15084237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
